U.S. pharma that makes potential coronavirus drug touted by Donald Trump doubled price to $19.88 a pill

Financial Post

20 March 2020 - Company calls hike in January during China outbreak coincidental and said it restored old price.

The only U.S. drug maker that makes a potential treatment for the coronavirus that was touted by President Donald Trump raised the price by almost 100 per cent in January, as the virus caused havoc across China.

Rising Pharmaceuticals, a New Jersey based company, increased the price of chloroquine — an antimalarial, which is one of the drugs that is being tested against COVID-19 — on Jan. 23, according to data from research firm Elsevier. The drug price rose 97.86 per cent to $7.66 per 250 mg pill and $19.88 per 500 mg pill.

Read Financial Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , COVID-19